A novel role of the tumor suppressor GNMT in cellular defense against DNA damage

Yi Cheng Wang, Wei Li Lin, Yan Jun Lin, Feng Yao Tang, Yi Ming Chen, En Pei Isabel Chiang

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Glycine N-methyltransferase (GNMT) is a folate binding protein commonly diminished in human hepatoma yet its role in tumor development remains to be established. GNMT binds to methylfolate but is also inhibited by it; how such interactions affect human carcinogenesis is unclear. We postulated that GNMT plays a role in folate-dependent methyl group homeostasis and helps maintain genome integrity by promoting nucleotide biosynthesis and DNA repair. To test the hypothesis, GNMT was over-expressed in GNMT-null cell lines cultured in conditions of folate abundance or restriction. The partitioning of folate dependent 1-carbon groups was investigated using stable isotopic tracers and GC/MS. DNA damage was assessed as uracil content in cell models, as well as in Gnmt wildtype (Gnmt +/+), heterozygote (Gnmt +/-) and knockout (Gnmt -/-) mice under folate deplete, replete, or supplementation conditions. Our study demonstrated that GMMT 1) supports methylene-folate dependent pyrimidine synthesis; 2) supports formylfolate dependent purine syntheses; 3) minimizes uracil incorporation into DNA when cells and animals were exposed to folate depletion; 4) translocates into nuclei during prolonged folate depletion. In conclusion, loss of GNMT impairs nucleotide biosynthesis. Over-expression of GNMT enhances nucleotide biosynthesis and improves DNA integrity by reducing uracil misincorporation in DNA both in vitro and in vivo. To our best knowledge, the role of GNMT in folate dependent 1-carbon transfer in nucleotide biosynthesis has never been investigated. The present study gives new insights into the underlying mechanism by which GNMT can participate in tumor prevention/suppression in humans. What's new Commonly absent in hepatocellular carcinoma is the liver protein glycine N-methyltransferase (GNMT), a proposed tumor suppressor. While GNMT and its role in preventing tumor formation have been studied extensively, this study reveals a hitherto unknown mechanism by which the protein may participate in tumor suppression. In knockout mice and engineered cell lines, GNMT deletion led to DNA damage in conditions of folate depletion. Furthermore, its overexpression not only improved cellular methylation kinetics but also enhanced DNA synthesis and repair, in both in vitro and in vivo model systems.

Original languageEnglish
Pages (from-to)799-810
Number of pages12
JournalInternational Journal of Cancer
Volume134
Issue number4
DOIs
Publication statusPublished - Feb 15 2014
Externally publishedYes

Fingerprint

Glycine N-Methyltransferase
DNA Damage
Folic Acid
Neoplasms
Uracil
Nucleotides
Knockout Mice
DNA Repair
Hepatocellular Carcinoma
DNA
Carbon
Protein Methyltransferases
Cell Line
Null Lymphocytes
Heterozygote

Keywords

  • glycine-N methyltransferase
  • nuclear folate metabolism
  • purine synthesis
  • pyrimidine synthesis
  • stable isotopic tracer studies
  • transmethylation metabolic kinetics
  • uracil misincorporation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

A novel role of the tumor suppressor GNMT in cellular defense against DNA damage. / Wang, Yi Cheng; Lin, Wei Li; Lin, Yan Jun; Tang, Feng Yao; Chen, Yi Ming; Chiang, En Pei Isabel.

In: International Journal of Cancer, Vol. 134, No. 4, 15.02.2014, p. 799-810.

Research output: Contribution to journalArticle

Wang, Yi Cheng ; Lin, Wei Li ; Lin, Yan Jun ; Tang, Feng Yao ; Chen, Yi Ming ; Chiang, En Pei Isabel. / A novel role of the tumor suppressor GNMT in cellular defense against DNA damage. In: International Journal of Cancer. 2014 ; Vol. 134, No. 4. pp. 799-810.
@article{b1ae817d802e43f7a9b6505b6030e853,
title = "A novel role of the tumor suppressor GNMT in cellular defense against DNA damage",
abstract = "Glycine N-methyltransferase (GNMT) is a folate binding protein commonly diminished in human hepatoma yet its role in tumor development remains to be established. GNMT binds to methylfolate but is also inhibited by it; how such interactions affect human carcinogenesis is unclear. We postulated that GNMT plays a role in folate-dependent methyl group homeostasis and helps maintain genome integrity by promoting nucleotide biosynthesis and DNA repair. To test the hypothesis, GNMT was over-expressed in GNMT-null cell lines cultured in conditions of folate abundance or restriction. The partitioning of folate dependent 1-carbon groups was investigated using stable isotopic tracers and GC/MS. DNA damage was assessed as uracil content in cell models, as well as in Gnmt wildtype (Gnmt +/+), heterozygote (Gnmt +/-) and knockout (Gnmt -/-) mice under folate deplete, replete, or supplementation conditions. Our study demonstrated that GMMT 1) supports methylene-folate dependent pyrimidine synthesis; 2) supports formylfolate dependent purine syntheses; 3) minimizes uracil incorporation into DNA when cells and animals were exposed to folate depletion; 4) translocates into nuclei during prolonged folate depletion. In conclusion, loss of GNMT impairs nucleotide biosynthesis. Over-expression of GNMT enhances nucleotide biosynthesis and improves DNA integrity by reducing uracil misincorporation in DNA both in vitro and in vivo. To our best knowledge, the role of GNMT in folate dependent 1-carbon transfer in nucleotide biosynthesis has never been investigated. The present study gives new insights into the underlying mechanism by which GNMT can participate in tumor prevention/suppression in humans. What's new Commonly absent in hepatocellular carcinoma is the liver protein glycine N-methyltransferase (GNMT), a proposed tumor suppressor. While GNMT and its role in preventing tumor formation have been studied extensively, this study reveals a hitherto unknown mechanism by which the protein may participate in tumor suppression. In knockout mice and engineered cell lines, GNMT deletion led to DNA damage in conditions of folate depletion. Furthermore, its overexpression not only improved cellular methylation kinetics but also enhanced DNA synthesis and repair, in both in vitro and in vivo model systems.",
keywords = "glycine-N methyltransferase, nuclear folate metabolism, purine synthesis, pyrimidine synthesis, stable isotopic tracer studies, transmethylation metabolic kinetics, uracil misincorporation",
author = "Wang, {Yi Cheng} and Lin, {Wei Li} and Lin, {Yan Jun} and Tang, {Feng Yao} and Chen, {Yi Ming} and Chiang, {En Pei Isabel}",
year = "2014",
month = "2",
day = "15",
doi = "10.1002/ijc.28420",
language = "English",
volume = "134",
pages = "799--810",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - A novel role of the tumor suppressor GNMT in cellular defense against DNA damage

AU - Wang, Yi Cheng

AU - Lin, Wei Li

AU - Lin, Yan Jun

AU - Tang, Feng Yao

AU - Chen, Yi Ming

AU - Chiang, En Pei Isabel

PY - 2014/2/15

Y1 - 2014/2/15

N2 - Glycine N-methyltransferase (GNMT) is a folate binding protein commonly diminished in human hepatoma yet its role in tumor development remains to be established. GNMT binds to methylfolate but is also inhibited by it; how such interactions affect human carcinogenesis is unclear. We postulated that GNMT plays a role in folate-dependent methyl group homeostasis and helps maintain genome integrity by promoting nucleotide biosynthesis and DNA repair. To test the hypothesis, GNMT was over-expressed in GNMT-null cell lines cultured in conditions of folate abundance or restriction. The partitioning of folate dependent 1-carbon groups was investigated using stable isotopic tracers and GC/MS. DNA damage was assessed as uracil content in cell models, as well as in Gnmt wildtype (Gnmt +/+), heterozygote (Gnmt +/-) and knockout (Gnmt -/-) mice under folate deplete, replete, or supplementation conditions. Our study demonstrated that GMMT 1) supports methylene-folate dependent pyrimidine synthesis; 2) supports formylfolate dependent purine syntheses; 3) minimizes uracil incorporation into DNA when cells and animals were exposed to folate depletion; 4) translocates into nuclei during prolonged folate depletion. In conclusion, loss of GNMT impairs nucleotide biosynthesis. Over-expression of GNMT enhances nucleotide biosynthesis and improves DNA integrity by reducing uracil misincorporation in DNA both in vitro and in vivo. To our best knowledge, the role of GNMT in folate dependent 1-carbon transfer in nucleotide biosynthesis has never been investigated. The present study gives new insights into the underlying mechanism by which GNMT can participate in tumor prevention/suppression in humans. What's new Commonly absent in hepatocellular carcinoma is the liver protein glycine N-methyltransferase (GNMT), a proposed tumor suppressor. While GNMT and its role in preventing tumor formation have been studied extensively, this study reveals a hitherto unknown mechanism by which the protein may participate in tumor suppression. In knockout mice and engineered cell lines, GNMT deletion led to DNA damage in conditions of folate depletion. Furthermore, its overexpression not only improved cellular methylation kinetics but also enhanced DNA synthesis and repair, in both in vitro and in vivo model systems.

AB - Glycine N-methyltransferase (GNMT) is a folate binding protein commonly diminished in human hepatoma yet its role in tumor development remains to be established. GNMT binds to methylfolate but is also inhibited by it; how such interactions affect human carcinogenesis is unclear. We postulated that GNMT plays a role in folate-dependent methyl group homeostasis and helps maintain genome integrity by promoting nucleotide biosynthesis and DNA repair. To test the hypothesis, GNMT was over-expressed in GNMT-null cell lines cultured in conditions of folate abundance or restriction. The partitioning of folate dependent 1-carbon groups was investigated using stable isotopic tracers and GC/MS. DNA damage was assessed as uracil content in cell models, as well as in Gnmt wildtype (Gnmt +/+), heterozygote (Gnmt +/-) and knockout (Gnmt -/-) mice under folate deplete, replete, or supplementation conditions. Our study demonstrated that GMMT 1) supports methylene-folate dependent pyrimidine synthesis; 2) supports formylfolate dependent purine syntheses; 3) minimizes uracil incorporation into DNA when cells and animals were exposed to folate depletion; 4) translocates into nuclei during prolonged folate depletion. In conclusion, loss of GNMT impairs nucleotide biosynthesis. Over-expression of GNMT enhances nucleotide biosynthesis and improves DNA integrity by reducing uracil misincorporation in DNA both in vitro and in vivo. To our best knowledge, the role of GNMT in folate dependent 1-carbon transfer in nucleotide biosynthesis has never been investigated. The present study gives new insights into the underlying mechanism by which GNMT can participate in tumor prevention/suppression in humans. What's new Commonly absent in hepatocellular carcinoma is the liver protein glycine N-methyltransferase (GNMT), a proposed tumor suppressor. While GNMT and its role in preventing tumor formation have been studied extensively, this study reveals a hitherto unknown mechanism by which the protein may participate in tumor suppression. In knockout mice and engineered cell lines, GNMT deletion led to DNA damage in conditions of folate depletion. Furthermore, its overexpression not only improved cellular methylation kinetics but also enhanced DNA synthesis and repair, in both in vitro and in vivo model systems.

KW - glycine-N methyltransferase

KW - nuclear folate metabolism

KW - purine synthesis

KW - pyrimidine synthesis

KW - stable isotopic tracer studies

KW - transmethylation metabolic kinetics

KW - uracil misincorporation

UR - http://www.scopus.com/inward/record.url?scp=84890116848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890116848&partnerID=8YFLogxK

U2 - 10.1002/ijc.28420

DO - 10.1002/ijc.28420

M3 - Article

AN - SCOPUS:84890116848

VL - 134

SP - 799

EP - 810

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 4

ER -